Ketamine and depression: a narrative review

A Corriger, G Pickering - Drug design, development and therapy, 2019 - Taylor & Francis
Depression is the third leading cause of disability in the world. Depressive symptoms may
be reduced within several weeks after the start of conventional antidepressants, but …

Perioperative intravenous ketamine for acute postoperative pain in adults

ECV Brinck, E Tiippana, M Heesen… - Cochrane Database …, 2018 - cochranelibrary.com
Background Inadequate pain management after surgery increases the risk of postoperative
complications and may predispose for chronic postsurgical pain. Perioperative ketamine …

[HTML][HTML] Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases—a systematic review and meta-analysis of clinical …

AS Vargas, Â Luís, M Barroso, E Gallardo, L Pereira - Biomedicines, 2020 - mdpi.com
Psilocybin is a naturally occurring tryptamine known for its psychedelic properties. Recent
research indicates that psilocybin may constitute a valid approach to treat depression and …

Point-of-care electrochemical sensor for selective determination of date rape drug “ketamine” based on core-shell molecularly imprinted polymer

SS Soliman, AM Mahmoud, MR Elghobashy… - Talanta, 2023 - Elsevier
Misuse of illicit drugs is a serious problem that became the primary concern for many
authorities worldwide. Point-of-care (POC) diagnostic tools can provide accurate and fast …

[HTML][HTML] Arylcyclohexylamine derivatives: pharmacokinetic, pharmacodynamic, clinical and forensic aspects

R Pelletier, B Le Daré, D Le Bouëdec… - International Journal of …, 2022 - mdpi.com
Since the 2000s, an increasing number of new psychoactive substances (NPS) have
appeared on the drug market. Arylcyclohexylamine (ACH) compounds such as ketamine …

[HTML][HTML] Non-parenteral ketamine for depression: a practical discussion on addiction potential and recommendations for judicious prescribing

J Swainson, LJ Klassen, S Brennan, P Chokka… - CNS drugs, 2022 - Springer
Intravenous (IV) ketamine is increasingly used off-label at subanesthetic doses for its rapid
antidepressant effect, and intranasal (IN) esketamine has been recently approved in several …

The emerging role of ketamine in acute postoperative pain management

AN Edinoff, D Askins, E Bobo, KL White… - Current Pain and …, 2023 - Springer
Abstract Purpose of Review Postoperative pain (POP) is among the most unpleasant
experiences that patients face after surgery. Interest in and use of N-methyl-D-aspartate …

[HTML][HTML] Ketamine in acute brain injury: current opinion following cerebral circulation and electrical activity

C Zanza, F Piccolella, F Racca, T Romenskaya… - Healthcare, 2022 - mdpi.com
The use of ketamine in patients with TBI has often been argued due to its possible
deleterious effects on cerebral circulation and perfusion. Early studies suggested that …

Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study

J Van Amsterdam, W Van Den Brink - Expert opinion on drug safety, 2022 - Taylor & Francis
Backgrounds Ketamine is a dissociative anesthetic that is currently considered for several
new indications. Aim To deduce the safety of long-term ketamine treatment using the harm of …

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey

V Bonnelle, WJ Smith, NL Mason… - British Journal of …, 2022 - journals.sagepub.com
Although several studies and reports have shown the potential analgesic use of
serotonergic psychedelics in cancer pain, phantom limb pain and cluster headache …